Download PDF
- Baxter International
- Overview
- Last Modified:
- May 28, 2025
- Company type:
- Public
- Industry:
- Healthcare
- Verified:
- No
- No of Employees:
- 50 001 - 100 000
- Stock Code:
- BAX
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- Deerfield, Illinois, U.S.
- Public Interest Score:
- 750+
- Baxter International
- General Information
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.
Patricia Morrison:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Stephen Oesterle:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Nancy Schlichting:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Brent Shafer:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Cathy Smith:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Amy Wendell:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
David Wilkes:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Peter Wilver:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jose Almeida:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Stephen Oesterle:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Nancy Schlichting:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Brent Shafer:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Cathy Smith:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Amy Wendell:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
David Wilkes:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Peter Wilver:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jose Almeida:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company risk rating
5 Benchmark > 4 Excellent > 3Â Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 14854
- Founded Year:
- 1931
- Registration Number:
- 36-0781620
- Country:
- United States of America
- Stock Exchanges:
-
- New York Stock Exchange
- Financial year end:
- December
- No. of Countries operations:
- 72
- Company Status:
- In Business
- Industry Sub Category:
- Drugs & Bio-technologies
- Date listed on Stock Exchange:
- 27/10/1981
- Contact Information
- Business operation:
- Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions.
- Primary office:
- Deerfield, 1 Baxter Pkwy, United States
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Ellen Bradford
- Reporting currency:
- USD
- ISIN number (12 digit):
NYSE
US0718131099- Authorised shares:
- 2 000 000 000
- Issued shares:
- 683 494 944
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 0 shareholders
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Shareholders holding 5% +
For a comprehensive list, please contact InsidEntity.
Material Subsidiaries/Associates
For a comprehensive list, please contact InsidEntity.
Credit Rating
| Name | Logo | Country | Headquarters | Rating |
|---|---|---|---|---|
| Fitch |  | United States of America | New York | BBB |
Countries Operations/ Offices
Company Directors
Name
Nationality
Age
Role
Qualification
Name
Patricia
Non ExecutiveNationalityAmerican
62
RoleNED
QualificationBS Secondary Education, BA Math & Statistics
Name
Stephen
Non ExecutiveNationalityAmerican
RoleNED
QualificationDoctor of Medicine MD, Bachelor of ARTS IN Chemistry
Name
Nancy
Non ExecutiveNationalityAmerican
70
RoleNED
QualificationMBA, Accounting and Hospital Administration
Name
Brent
Non ExecutiveNationalityAmerican
RoleNED
QualificationNot available
Name
Cathy
Non ExecutiveNationalityAmerican
RoleNED
QualificationBA Business Economics, MBA
Name
Amy
Non ExecutiveNationalityAmerican
56
RoleNED
QualificationBachelors Mechanical Engineering, Masters Biomedical Engineering
Name
David
Non ExecutiveNationalityAmerican
68
RoleNED
QualificationBachelors of Science, MD
Name
Peter
Non ExecutiveNationalityAmerican
RoleNED
QualificationNot available
Name
Jose
ExecutiveNationalityAmerican
64
RoleCEO
QualificationBSc Mechanical Engineering
Directors Tenure
Name
Duration
Director Experience
Name
Experience
Company Auditors
Name
Date Appointed
Years
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|